JRP-878

N/A

Report date: 2025/01/26 18:12:31
NME

Base Information

Drug NameJRP-878
Drug Alias Namemuscarinic M3 antagonist (Prous Institute)JRP-878
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProus Institute For Biomedical Research Sa
China Registration ClassN/A

Develop Information

Active CompaniesProus Institute For Biomedical Research Sa
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A